Navigation Links
Align Technology to Announce First Quarter Fiscal 2009 Results on April 23, 2009
Date:4/2/2009

clusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998. Today, the Invisalign product family includes Invisalign, Invisalign Teen, Invisalign Assist, Invisalign Express, and Vivera Retainers.

To learn more about Invisalign or to find a certified Invisalign doctor in your area, please visit www.invisalign.com or call 1-800-INVISIBLE.

    Investor Relations Contact
    Shirley Stacy
    Align Technology, Inc.
    (408) 470-1150
    sstacy@aligntech.com

    Press Contact
    Shannon Mangum Henderson
    Ethos Communication, Inc.
    (678) 540-9222
    align@ethoscommunication.com


'/>"/>
SOURCE Align Technology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. NovaLign(TM) Orthopaedics, Inc. Announces its First 510(K) Clearance From the FDA for New Intramedullary Fixation System
2. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
3. Dr. James F. Pingpank to Present at the Sixth International Symposium on Melanoma and Other Cutaneous Malignancies on March 13- 14, 2009 in New York City
4. A new measure for the malignancy of melanoma
5. Align Technology Names Sheila Tan as VP, Marketing and Chief Marketing Officer
6. Precyse Solutions Adds Executives, Realigns Around Service Lines
7. Align Technology Announces International Availability of Invisalign Teen(TM)
8. EMSI Realigns Internal Divisions for More Effective Focus on Customers
9. Video: The MDS Foundation Says Published Data Confirms VIDAZA(R) Significantly Extends Survival in Patients with the Malignant Condition MDS
10. Align Technology Asserts ClearCorrect Complaint Is Without Merit
11. Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... ... For Dallas, the time is nearing for the annual Heart Walk, and North ... American Heart Association hosts their well-known Heart Walk to raise money in awareness and ... be made. Walkers can participate in the cause and someone can also donate, even ...
(Date:8/28/2015)... ... 28, 2015 , ... As reported by Medical Daily on August 22 ... results that last for two years, the longest of any cellulite reduction system currently ... for a long-lasting, effective solution for their cellulite, according to Dr. Robert Weiss, director ...
(Date:8/28/2015)... Manistee, Michigan (PRWEB) , ... August 28, 2015 , ... ... in Western Michigan, joined as sponsor of the “Music With A Mission” benefit concert ... purpose behind the event was to raise money to support music education programs in ...
(Date:8/28/2015)... ... , ... Saint Petersburg, FL —Pocket Protein™, a protein beverage ... gluten, lactose or caffeine in a convenient 2 oz. pouch that never needs ... Awards. , Five consumer packaged goods (CPG) products were selected by the SupplySide ...
(Date:8/28/2015)... ... , ... Altima Technologies, Inc., the maker of popular NetZoom™ ... and audio-video devices, recently released Visio Stencils for the following product lines: ... VNX Series , Super Micro Computer SuperStorage, Hitachi Data Systems Virtual Storage Series, ...
Breaking Medicine News(10 mins):Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3
... cell research, experts say , , MONDAY, Nov. 3 (HealthDay ... mice from mouse bodies that had been frozen for ... raise the specter of resurrecting lost species a la ... said recreating woolly mammoths was "probably impossible." , ...
... study conducted by researchers at Georgia State University is ... of preemptive morphine prior to a painful procedure in ... adult rodents. These studies have serious implications for ... prior to surgery. Infant rodents that did not receive ...
... efforts to educate the public about HIV, a new ... University and Children,s Hospital Boston has found that two-thirds ... spreading HIV in the home. , The qualitative study ... minor children, in families with an HIV-infected parent about ...
... at the University of California, San Diego (UCSD) are ... revving up the immune system to combat a particularly ... is being offered to patients with chronic lymphocytic leukemia ... to initial treatment or harbors a particular chromosomal abnormality ...
... which claimed that homeopathy is just a placebo, published in ... George Lewith, Professor of Health Research at Southampton University comments: ... nor of the various vital assumptions made about the data. ... homeopathy works for some conditions but not others, or change ...
... increases 32% to $16.0 million. - Heart valve therapy products revenue rises 39.1% ... surgical ablation products revenue grows 21.7%. - Third quarter gross profit ... 2008 revenue guidance to $65 - $66 ... million., MINNEAPOLIS, Nov. ...
Cached Medicine News:Health News:Scientists Make Clones of Mice Dead 16 Years 2Health News:GSU study first to confirm long-term benefits of morphine treatment in infants 2Health News:Study finds fears of HIV transmission in families with infected parent 2Health News:Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patients 2Health News:New evidence for homeopathy 2Health News:ATS Medical Announces Third Quarter Results 2Health News:ATS Medical Announces Third Quarter Results 3Health News:ATS Medical Announces Third Quarter Results 4Health News:ATS Medical Announces Third Quarter Results 5Health News:ATS Medical Announces Third Quarter Results 6Health News:ATS Medical Announces Third Quarter Results 7Health News:ATS Medical Announces Third Quarter Results 8
(Date:8/28/2015)... 28, 2015 Research ... of the "Investigation Report on China,s Insulin ... Developed by Novo Nordisk, insulin aspart ... important drug for the treatment of diabetes. Compared ... acting insulin analog, starts working fast and reports ...
(Date:8/28/2015)... 28, 2015  IP Shakti, LLC, today announced that it ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... new corporate identity signifies our transformation into a company focused ... platform for patent claim validity." ... proprietary AIA Shield™ platform, the Company commenced a corporate re-branding ...
(Date:8/28/2015)... and PITTSBURGH , ... MYL ) today announced that its shareholders have ... (NYSE: PRGO ; TASE) and the related ... at an extraordinary general meeting of shareholders held ... votes cast at the extraordinary general meeting. In ...
Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9
... 8, 2011 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... Extension Study presented at ESCWhen: , Monday, September 12, 2011 ... , Live on the Internet.  Simply log onto our Web ... the live event, a replay of the webcast will be ...
... 8, 2011 Anthera Pharmaceuticals, Inc. (Nasdaq: ... to treat serious diseases associated with inflammation, today ... has given the Company a Notice of Allowance ... of cardiovascular disease and dyslipidemia using secretory phospholipase ...
Cached Medicine Technology:Anthera Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application Covering A-002 Plus Statin Compositions 2Anthera Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application Covering A-002 Plus Statin Compositions 3
Thermometer for Round Water Bath...
... The F340 is a basic laboratory system ... pH results can be obtained when used ... 3-in-1 electrode. • Fast and easy one ... recognition for five buffers (pH 1.68, 4.00, ...
... - the multifunctional high-end microplate reader with ... detection modes., Fluorescence Intensity - FRET ... - HTRF, AlphaScreen , Luminescence ... dual emission microplate reader with fastest read ...
GENios Pro, TECANs advanced, multi-functional injector reader offers simultaneous reagent dispensing and detection for monitoring of fast kinetic reactions...
Medicine Products: